Theriva Biologics (TOVX) Q3 2026 Earnings

12AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-1.93
-1.3
-0.68
-0.05

Details

Expected EPS
-0.055
Actual EPS
N/A
Surprise EPS
0.06
Surprise Percent
+100%

Description

Theriva Biologics (TOVX) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts